Literature DB >> 16485015

Lifetime visual prognosis for patients with primary open-angle glaucoma.

G S Ang1, T Eke.   

Abstract

AIM: To investigate final visual outcome in primary open angle glaucoma (POAG) including low-tension glaucoma (LTG).
METHODS: Retrospective review of case notes for patients who died between 1999 and 2002. All were booked for a follow-up appointment in glaucoma clinic at time of death.
RESULTS: A total of 121 case notes were reviewed. In all, 113 patients had POAG and eight had LTG. All were White Caucasians. Mean ages at presentation and death were 74.6 (SD 9.6, range 49-94) and 81.9 (SD 8.3, range 51-98) years, respectively. Mean follow-up duration was 7.4 (SD 6.8, range up to 29) years. Average number of clinic visits was 18 (SD 17, range 1-95). At final visit, 50.4% had cataract operations, and 45.5% had glaucoma operations. At final visit, vision was inadequate for driving in the UK in 47.1%. In 18.2%, this was due to glaucoma alone, while in 28.9%, other ocular pathologies contributed to poor vision. In all, 14% were eligible for partial sight certification, with 6.6% due to glaucoma alone. A total of 3.3% were eligible for blind certification, none due to glaucoma alone.
CONCLUSION: This study shows that POAG does affect the quality of life, with regards to glaucoma clinic visits, eye drops, and surgical procedures. Most patients with treated POAG in Norfolk will retain useful vision for their whole life. A significant proportion of patients with POAG do lose vision resulting in driving ineligibility and certification as visually impaired, although actual blindness is uncommon.

Entities:  

Mesh:

Year:  2006        PMID: 16485015     DOI: 10.1038/sj.eye.6702284

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

1.  Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability.

Authors:  Gwendolyn Gramer; Eugen Gramer
Journal:  Int Ophthalmol       Date:  2017-02-27       Impact factor: 2.031

2.  The impact of change in visual field on health-related quality of life the los angeles latino eye study.

Authors:  Cecilia M Patino; Rohit Varma; Stanley P Azen; David V Conti; Michael B Nichol; Roberta McKean-Cowdin
Journal:  Ophthalmology       Date:  2011-03-31       Impact factor: 12.079

3.  Incorporating life expectancy in glaucoma care.

Authors:  C Wesselink; R Stoutenbeek; N M Jansonius
Journal:  Eye (Lond)       Date:  2011-09-09       Impact factor: 3.775

4.  Psychometric Evaluation of Glaucoma Quality of Life Item Banks (GlauCAT) and Initial Assessment Using Computerized Adaptive Testing.

Authors:  Ryan Eyn Kidd Man; Eva K Fenwick; Jyoti Khadka; ZhiChao Wu; Simon Skalicky; Konrad Pesudovs; Ecosse L Lamoureux
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

5.  Predictors of Early Onset Glaucoma.

Authors:  Jeffrey Wooliscroft; Rubeel Akram; Hafsa Zuberi; Betty Tong; Jane Gu; Aaron Hurd; Karanjit Kooner
Journal:  Clin Ophthalmol       Date:  2022-06-10

6.  Exploring eye movements in patients with glaucoma when viewing a driving scene.

Authors:  David P Crabb; Nicholas D Smith; Franziska G Rauscher; Catharine M Chisholm; John L Barbur; David F Edgar; David F Garway-Heath
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

7.  The socioeconomic impact among Egyptian glaucoma patients.

Authors:  Mohamed Eldaly; Mostafa Hunter; Mohamed Khafagy
Journal:  Br J Ophthalmol       Date:  2007-10       Impact factor: 4.638

8.  Evaluating clinical change and visual function concerns in drivers and nondrivers with glaucoma.

Authors:  Nancy K Janz; David C Musch; Brenda W Gillespie; Patricia A Wren; Leslie M Niziol
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

Review 9.  Biochemical changes and treatment in glaucoma.

Authors:  I M Ciotu; I Stoian; L Gaman; M V Popescu; V Atanasiu
Journal:  J Med Life       Date:  2015 Jan-Mar

10.  Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.

Authors:  Anthony J King; Gordon Fernie; Augusto Azuara-Blanco; Jennifer M Burr; Ted Garway-Heath; John M Sparrow; Luke Vale; Jemma Hudson; Graeme MacLennan; Alison McDonald; Keith Barton; John Norrie
Journal:  Br J Ophthalmol       Date:  2017-10-26       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.